Lac-hydrin and Catapres drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lac-hydrin (ammonium lactate) and Catapres (clonidine hydrochloride). Common drug interactions include bile duct stone among females and intra-abdominal haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Lac-hydrin and Catapres. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Lac-hydrin?

Lac-hydrin has active ingredients of ammonium lactate. eHealthMe is studying from 534 Lac-hydrin users. Check the latest studies of Lac-hydrin.

What is Catapres?

Catapres has active ingredients of clonidine hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 6,680 Catapres users. Check the latest studies of Catapres.



On Nov, 03, 2025

13 people who take Lac-hydrin and Catapres together, and have interactions are studied.

Lac-hydrin and Catapres drug interactions.

What are the common drug interactions of Lac-Hydrin and Catapres, by gender? *:

female:

  1. Bile duct stone
  2. Physical disability
  3. Biliary cirrhosis (biliary cirrhosis occurs due to obstruction to the flow of bile through bile ducts either within the liver or outside the liver)
  4. Blood triglycerides increased
  5. Cardiac disorder
  6. Cardiomegaly (increased size of heart than normal)
  7. Constipation
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Cushingoid (obesity and weakening of the muscles)
  10. Dizziness

male:

  1. Intra-abdominal haemorrhage (intra-abdominal bleeding)
  2. Adhesion
  3. Haemorrhagic ascites (abnormal accumulation of fluid in the abdomen with blood)
  4. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  5. Small intestinal obstruction (blockage in small intestine)

What are the common drug interactions of Lac-Hydrin and Catapres, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal distension
  2. Cardiac failure
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Diarrhoea
  5. Impaired work ability
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Oedema peripheral (superficial swelling)
  8. Pain
  9. Pericardial effusion (fluid around the heart)
  10. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)

50-59:

  1. Constipation
  2. Spinal column stenosis (narrowing of spinal column)
  3. Stasis dermatitis (skin inflammation caused by blood pooling in the veins in your legs)
  4. Tonsillitis (inflammation of tonsil)
  5. Upper extremity mass
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Cushingoid (obesity and weakening of the muscles)
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Dizziness
  10. Dysphagia (a condition in which swallowing is difficult or painful)

60+:

  1. Adhesion
  2. Haemorrhagic ascites (abnormal accumulation of fluid in the abdomen with blood)
  3. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  4. Small intestinal obstruction (blockage in small intestine)
  5. Drug hypersensitivity

What are the existing conditions these people have? *

  1. Back Pain: 5 people, 38.46%
  2. High Blood Cholesterol: 4 people, 30.77%
  3. Diabetes: 4 people, 30.77%
  4. Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 23.08%
  5. Pain In Extremity: 3 people, 23.08%
  6. Pain: 3 people, 23.08%
  7. Immunodeficiency Disorders: 3 people, 23.08%
  8. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 23.08%
  9. Hypotension (abnormally low blood pressure): 3 people, 23.08%
  10. Skin Ulcer: 3 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take Lac-hydrin and Catapres?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lac-hydrin and Catapres:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lac-hydrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Catapres:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lac-hydrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Catapres and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ammonium lactate and clonidine hydrochloride (the active ingredients of Lac-hydrin and Catapres, respectively), and Lac-hydrin and Catapres (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: